To the Editors:
In a recent issue of the European Respiratory Journal, Andreas et al. 1 explored the effect of the angiotensin II type-1 receptor blocker irbesartan on skeletal and respiratory muscle strength in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage III and IV chronic obstructive pulmonary …